Viewing Study NCT06439602


Ignite Creation Date: 2025-12-25 @ 3:49 AM
Ignite Modification Date: 2026-04-24 @ 9:51 AM
Study NCT ID: NCT06439602
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-15
First Post: 2024-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
Sponsor: Arthrosi Therapeutics
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Gout View
None Arthritis, Gouty View
None Hyperuricemia View
None Gout Chronic View
Keywords: